Veropharm nine-month net profit up 14 pct to 833 mln rbls

Veropharm, one of Russia's largest drug makers, increased its IFRS net profit in the first nine months of 2010 by 14 percent year-on-year to 833.6 million rubles ($26.7 million), the company said on Friday.

Veropharm's sales in January-September 2010 grew by 22.4 percent to 3.934 billion rubles compared with the same period in 2009, the company said.

MOSCOW, November 26 (RIA Novosti)